Performance of Plasma Adenosine as a Biomarker for Predicting Cardiovascular Risk
Trevor Simard(University of Ottawa), Benjamin Hibbert(Mayo Clinic), Michael Froeschl(University of Ottawa), Aun‐Yeong Chong(University of Ottawa), Juan Russo(University of Ottawa), Richard G. Jung(University of Ottawa), Robert B. Moreland(University of Ottawa), Paul Boland(University of Ottawa), Alisha Labinaz(University of Ottawa), Pouya Motazedian(University of Ottawa), Pietro Di Santo(University of Ottawa), Joanne Joseph(University of Ottawa), Derek So(University of Ottawa), F. Daniel Ramirez(University of Ottawa), Chantal Gaudet(University of Ottawa), Steven Promislow(University of Ottawa), Simon Parlow(University of Ottawa), Michel Le May(University of Ottawa), Jeffrey A. Marbach(Tufts Medical Center)
Cited by 10
Related Papers
Left Ventricular Unloading During Extracorporeal Membrane Oxygenation in Patients With Cardiogenic Shock
|Journal of the American College of Cardiology|2019|398
Association between complications and death within 30 days after noncardiac surgery
|Canadian Medical Association Journal|2019|348
Increased circulating platelet–leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis
|British Journal of Haematology|2001|261
<i>RIPK1</i> Expression Associates With Inflammation in Early Atherosclerosis in Humans and Can Be Therapeutically Silenced to Reduce NF-κB Activation and Atherogenesis in Mice
|Circulation|2020|233
Methodological quality of COVID-19 clinical research
|Nature Communications|2021|191